ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980